BioCentury
ARTICLE | Company News

Chattem, sanofi-aventis deal

February 15, 2010 8:00 AM UTC

sanofi-aventis completed its previously announced tender offer for Chattem, acquiring about 18.6 million shares (90%) for $93.50 per share or about $1.7 billion in cash. sanofi-aventis plans to acquir...